| 000 | 01261 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250510214453.0 | ||
| 264 | 0 | _c19760925 | |
| 008 | 197609s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.26.8.741 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKartzinel, R | |
| 245 | 0 | 0 |
_aStudies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism. _h[electronic resource] |
| 260 |
_bNeurology _cAug 1976 |
||
| 300 |
_a741-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aBromocriptine _xadministration & dosage |
| 650 | 0 | 4 |
_aCaffeine _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aErgolines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aPhosphodiesterase Inhibitors |
| 700 | 1 | _aShoulson, I | |
| 700 | 1 | _aCalne, D B | |
| 773 | 0 |
_tNeurology _gvol. 26 _gno. 8 _gp. 741-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.26.8.741 _zAvailable from publisher's website |
| 999 |
_c178176 _d178176 |
||